banner add

Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

October 23, 2025 0
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.

from NYT > Health https://ift.tt/NWShtOr
via IFTTT
Tags:

No comments

Subscribe to: Post Comments ( Atom )

Brenna Henn Wanted to Improve Genetic Medicine. Then Her N.I.H. Grant Was Cut.

Brenna Henn had a long-term grant to study the genetic diversity of Africans and people of African descent. Then her N.I.H. funding was cut....

Theme images by PLAINVIEW. Powered by Blogger.